Monoclonal Antibodies
Anti-PHD2/EGLN1 Rabbit Monoclonal Antibody for WB, ELISA - Q9GZT9
Item Number : CM0002656
Price varies based on specs and customizations
- Application
- WB, ELISA
- Cross Reactivity
- Human
- Protein Weight
- 46kDa
Shipping:
Contact us to get shipping details Enjoy On-time Dispatch Guarantee.
Why Choose Us
Easy ordering process, quality products, and dedicated support for your business success.
Core Product Specifications and Parameters
| Parameter | Value |
|---|---|
| Product Name | [KO Validated] PHD2/EGLN1 Rabbit mAb |
| Remarks/Alias | HPH2; PHD2; SM20; ECYT3; HALAH; HPH-2; HIFPH2; ZMYND6; C1orf12; HIF-PH2; N1 |
| Species | Human |
| Gene ID (Human) | 54583 |
| Gene ID | 54583 |
| Immunogen | A synthetic peptide corresponding to a sequence within amino acids 1-100 of human PHD2/EGLN1 (NP_071334.1) |
| Source | Rabbit |
| Category | Monoclonal Antibodies |
| Application | WB, ELISA |
| Cross Reactivity | Human |
| SWISS | Q9GZT9 |
| Protein Weight | 46kDa |
| Shipping | Ice bag |
Biological Background: PHD2/EGLN1 Function and Localization
- PHD2/EGLN1, also known as Egl nine homolog 1 or HIF-prolyl hydroxylase 2 (HIF-PH2), is a cellular oxygen sensor belonging to the prolyl hydroxylase domain-containing protein family.
- Under normoxic conditions, it catalyzes the hydroxylation of specific proline residues within the oxygen-dependent degradation domain of hypoxia-inducible factor alpha (HIF-α) subunits, marking them for von Hippel-Lindau-mediated ubiquitination and proteasomal degradation.
- This enzymatic activity requires iron, 2-oxoglutarate, and vitamin C as cofactors, and is attenuated under hypoxia, allowing HIF-α stabilization and translocation to the nucleus to induce hypoxic gene expression.
- The protein localizes to both the cytoplasm and nucleus, and is widely expressed in human tissues, with highest levels in heart, brain, skeletal muscle, and kidney.
- Post-translational modifications include acetylation, phosphorylation, and S-nitrosylation, which may modulate its activity; alternative splicing generates multiple isoforms.
- Mutations in EGLN1 are associated with congenital erythrocytosis type 3 (ECYT3), highlighting its critical role in erythropoiesis and oxygen homeostasis.
Experimental Guidance and Technical Tips
- The antibody is raised against a synthetic peptide spanning amino acids 1-100 of human PHD2/EGLN1. Consider that this N-terminal epitope may detect multiple isoforms or cleavage fragments; validate the observed bands in your specific experimental context.
- For Western blot, the predicted molecular weight is approximately 46 kDa. Using positive controls such as lysates from normoxic versus hypoxic cells can help confirm the specificity of the signal.
- The antibody is suitable for ELISA and WB on human samples. Cross-reactivity with other species has not been tested; if used in non-human models, thorough validation is recommended.
- Optimal dilution and incubation conditions should be determined empirically for each application and sample type.
CamelBio: Your One-Stop Sourcing Bridge
CamelBio is your comprehensive partner for IVD raw materials, providing validated antibody pairs, optimized monoclonal antibodies, and bulk ancillary reagents to streamline diagnostic development. With deep expertise in hypoxia signaling targets like PHD2/EGLN1, we ensure reliable sourcing for your assay manufacturing needs. From concept to clinic, CamelBio accelerates your workflow with tailored, one-stop access to critical and rare raw materials.
Product Datasheet
Anti-PHD2/EGLN1 Rabbit Monoclonal Antibody for WB, ELISA - Q9GZT9
REQUEST A QUOTE
Our professional team will reply to you within one business day. Please feel free to contact us!